184033-42-9Relevant articles and documents
Three-Dimensional Porous Architectures Based on MnII/III Three-Blade Paddle Wheel Metallacryptates
Marzaroli, Vittoria,Spigolon, Giulia,Lococciolo, Giuseppe,Quaretti, Martina,Salviati, Clarissa,Kampf, Jeff W.,Licini, Giulia,Marchiò, Luciano,Pecoraro, Vincent L.,Tegoni, Matteo
, p. 1954 - 1964 (2019/03/02)
Three metallacryptate supramolecular assemblies have been obtained using salicylhydroxamic acid derivatives (H3L). The three ligands differ in the residue at the para position with respect to the hydroxamic function (-H, -NH2, and -(
Design, synthesis, and biological evaluation of highly potent small molecule-peptide conjugates as new HIV-1 fusion inhibitors
Wang, Chao,Shi, Weiguo,Cai, Lifeng,Lu, Lu,Wang, Qian,Zhang, Tianhong,Li, Jinglai,Zhang, Zhenqing,Wang, Kun,Xu, Liang,Jiang, Xifeng,Jiang, Shibo,Liu, Keliang
, p. 2527 - 2539 (2013/05/21)
The small molecule fusion inhibitors N-(4-carboxy-3-hydroxyphenyl)-2,5- dimethylpyrrole (NB-2) and N-(3-carboxy-4-hydroxyphenyl)-2,5-dimethylpyrrole (A12) target a hydrophobic pocket of HIV-1 gp41 and have moderate anti-HIV-1 activity. In this
URETHANES, UREAS, AMIDINES AND RELATED INHIBITORS OF FACTOR XA
-
Page/Page column 28, (2011/10/03)
The invention relates to a new class of compounds, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions that are effective as selective inhibitors of factor Xa, both in the isolated state and in a complex with other proteins. The compounds of the invention can be used for treating and preventing diseases, such as acute coronary syndrome, myocardial infarction, unstable angina, refractory angina, thromboses caused by post-thrombolytic therapy or coronary angioplasty, acute ischemia mediated cerebrovascular syndrome, embolic stroke, thrombotic stroke, and other diseases in humans and other mammals associated with blood coagulation problems.
